VIVO

Meridian Bioscience Inc. Press Releases

$16.86
*  
0.56
3.44%
Get VIVO Alerts
*Delayed - data as of Dec. 17, 2014  -  Find a broker to begin trading VIVO now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
View:    VIVO Pre-Market
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Meridian Life Science Awarded SBIR II by Centers for Disease Control and Prevention to Develop Rotavirus Vaccine
12/2/2014 6:00:00 AM - Business Wire
▲2.12 % Price Change since this news event. The Volume Ratio is 0.96.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day


GlobalSign Debuts New Identity Relationship and Access Management Solutions That Deliver New Business Models for the Extended Enterprise
12/2/2014 6:00:00 AM - Market Wire


Meridian Bioscience Reports Fourth Quarter and Full-Year Operating Results, Declares Regular Cash Dividend, and Reaffirms Fiscal 2015 Guidance
11/6/2014 7:30:00 AM - Business Wire
▼-10.22 % Price Change since this news event. The Volume Ratio is 2.74.This reflects the trading volume for the event day.  Source: NewsQuantified.com
Volume ratio on event day